Schroder Investment Management Group boosted its position in Stem, Inc. (NYSE:STEM – Get Rating) by 98.6% during the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 6,111,511 shares of the company’s stock after acquiring an additional 3,033,830 shares during the period. Schroder Investment Management Group owned 3.96% of Stem worth $54,637,000 as of its most recent SEC filing.
A number of other hedge funds and other institutional investors have also added to or reduced their stakes in STEM. Renaissance Technologies LLC bought a new stake in Stem in the 1st quarter valued at about $30,405,000. Encompass Capital Advisors LLC bought a new stake in shares of Stem during the third quarter valued at about $33,350,000. Decade Renewable Partners LP bought a new stake in shares of Stem during the fourth quarter valued at about $9,926,000. Vanguard Group Inc. increased its position in shares of Stem by 7.0% during the first quarter. Vanguard Group Inc. now owns 12,934,965 shares of the company’s stock valued at $142,414,000 after buying an additional 848,277 shares during the period. Finally, Nuveen Asset Management LLC increased its position in shares of Stem by 121.8% during the third quarter. Nuveen Asset Management LLC now owns 1,411,759 shares of the company’s stock valued at $18,833,000 after buying an additional 775,318 shares during the period. 52.10% of the stock is currently owned by institutional investors.
Insider Transactions at Stem
In related news, CEO John Eugene Carrington sold 13,216 shares of the firm’s stock in a transaction on Monday, March 20th. The stock was sold at an average price of $6.33, for a total value of $83,657.28. Following the completion of the sale, the chief executive officer now owns 111,422 shares of the company’s stock, valued at $705,301.26. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. In related news, CEO John Eugene Carrington sold 13,216 shares of the firm’s stock in a transaction on Monday, March 20th. The stock was sold at an average price of $6.33, for a total value of $83,657.28. Following the completion of the sale, the chief executive officer now owns 111,422 shares of the company’s stock, valued at $705,301.26. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider Kim Homenock sold 27,063 shares of the firm’s stock in a transaction on Wednesday, March 15th. The shares were sold at an average price of $6.72, for a total value of $181,863.36. Following the transaction, the insider now directly owns 69,731 shares of the company’s stock, valued at approximately $468,592.32. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 48,132 shares of company stock worth $297,875. Insiders own 9.12% of the company’s stock.
Stem Price Performance
Stem (NYSE:STEM – Get Rating) last issued its earnings results on Thursday, May 4th. The company reported ($0.29) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.24) by ($0.05). Stem had a negative return on equity of 26.02% and a negative net margin of 37.59%. The firm had revenue of $67.00 million during the quarter, compared to the consensus estimate of $63.34 million. During the same quarter in the prior year, the business posted ($0.21) EPS. The firm’s revenue for the quarter was up 63.4% on a year-over-year basis. As a group, research analysts predict that Stem, Inc. will post -0.64 earnings per share for the current year.
Stem declared that its Board of Directors has authorized a stock repurchase plan on Wednesday, May 3rd that authorizes the company to buyback $500.00 million in shares. This buyback authorization authorizes the company to repurchase up to 81.1% of its stock through open market purchases. Stock buyback plans are typically a sign that the company’s board of directors believes its shares are undervalued.
Wall Street Analysts Forecast Growth
Several equities research analysts have recently weighed in on STEM shares. Morgan Stanley decreased their price target on Stem from $15.00 to $12.00 and set an “overweight” rating on the stock in a research report on Monday, April 3rd. TD Cowen decreased their price target on Stem from $11.00 to $8.00 and set an “outperform” rating on the stock in a research report on Friday, May 5th. The Goldman Sachs Group cut their price objective on Stem from $14.00 to $12.00 and set a “buy” rating for the company in a report on Thursday, March 30th. Susquehanna cut their price objective on Stem from $17.00 to $12.00 and set a “positive” rating for the company in a report on Thursday, March 30th. Finally, Bank of America lowered Stem from a “neutral” rating to an “underperform” rating and cut their price objective for the stock from $9.00 to $5.00 in a report on Tuesday, April 4th. One analyst has rated the stock with a sell rating, three have given a hold rating and ten have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, Stem presently has a consensus rating of “Moderate Buy” and a consensus target price of $12.42.
Stem Company Profile
Stem, Inc operates as a digitally connected and intelligent energy storage network provider in the United States and internationally. It offers energy storage systems sourced from original equipment manufacturers (OEMs). The company also provides Athena, an artificial intelligence platform, which offers battery hardware and software-enabled services to operate the energy storage systems.
- Get a free copy of the StockNews.com research report on Stem (STEM)
- Hot Inflation, What It Means For The Summer Rally
- 3 Electrical Gear Makers: Hidden Gems Amid Growing Digitization
- Can ULTA’s Defensive Product Line Stand Against This Down Cycle
- A Reversal Is Brewing For Medtronic: Buying The Dip
- Ralph Lauren’s Styled Dividend Is Still In Season
Receive News & Ratings for Stem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stem and related companies with MarketBeat.com's FREE daily email newsletter.